Improvising the base; adding new avenues for growth

Company
26 Aug 2024
5 Min read 
  • Mankind Pharma's financial snapshot and stock information include sales, EBITDA, and financial ratios.
  •  Growth initiatives focus on chronic therapies and consumer wellness for future expansion.
  •  Acquisition of BSV provides access to specialty portfolio and new geographies.
  •  Initiatives aim to improve share of chronic therapies and consumer healthcare focus.
  •  Expansion plans include launching differentiated products and market diversification.
  •  Improved capacity utilization impacts free cash flow and return on equity.
Login / Open Demat Account to read the report

Never Miss Out on Hot Market Updates

Get exclusive market news delivered to your inbox - on priority